Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer
Clinical trial NCT06562920 · RECRUITING
Trial details
- NCT number
- NCT06562920
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2027-07-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.